Procyon Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,495
| Closed | -$398K | – | 510 |
|
|
2025
Q1 | $398K | Sell |
5,495
-13
| -0.2% | -$942 | 0.02% | 416 |
|
|
2024
Q4 | $408K | Sell |
5,508
-132
| -2% | -$9.77K | 0.03% | 367 |
|
|
2024
Q3 | $373K | Sell |
5,640
-55
| -1% | -$3.63K | 0.03% | 395 |
|
|
2024
Q2 | $526K | Sell |
5,695
-351
| -6% | -$32.4K | 0.04% | 304 |
|
|
2024
Q1 | $578K | Sell |
6,046
-17
| -0.3% | -$1.63K | 0.04% | 303 |
|
|
2023
Q4 | $462K | Buy |
6,063
+384
| +7% | +$29.3K | 0.04% | 329 |
|
|
2023
Q3 | $393K | Buy |
+5,679
| New | +$393K | 0.04% | 337 |
|
|
2020
Q3 | – | Sell |
-434
| Closed | -$30K | – | 446 |
|
|
2020
Q2 | $30K | Buy |
434
+5
| +1% | +$346 | 0.02% | 465 |
|
|
2020
Q1 | $27K | Buy |
429
+315
| +276% | +$19.8K | 0.02% | 425 |
|
|
2019
Q4 | $9K | Buy |
+114
| New | +$9K | 0.01% | 680 |
|